Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Polycystic ovary syndrome (PCOS)

Polycystic ovary syndrome (PCOS) DOI: 10.1111/tog.12345 2017;19:119–29 Review The Obstetrician & Gynaecologist http://onlinetog.org Adam H Balen MD DSc FRCOG* Leeds Centre for Reproductive Medicine, Leeds Teaching Hospitals, Leeds, LS14 6UH, UK *Correspondence: Adam H Balen. Email: a.balen@nhs.net Accepted on 25 July 2016. Published Online 21 January 2017. Key content To appreciate the role of insulin resistance and the long-term The symptoms of polycystic ovary syndrome (PCOS) include health implications for women with PCOS. menstrual cycle disturbance and features of hyperandrogenism To understand how to manage the issues that may affect a woman (hirsutism, acne and alopecia), with associated fertility problems, in different ways at different times in her life, namely menstrual obesity and psychological issues. cycle irregularity, hyperandrogenism and infertility. There are ethnic variations in expression of PCOS related to Ethical issues differences in insulin metabolism and this may impact upon A contentious issue is the appropriateness to deny fertility treatment algorithms. treatment based upon a cut-off for body mass index (BMI), when Obesity has a major impact on the expression of PCOS and the BMI is a crude measure of metabolic risk and the risks of efficacy of the management of all aspects of the syndrome, in conception at a high BMI http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Obstetrician & Gynaecologist Wiley

Polycystic ovary syndrome (PCOS)

Balen, Adam H
The Obstetrician & Gynaecologist , Volume 19 (2) – Apr 1, 2017
Download PDF
11 pages

Loading next page...
 
/lp/wiley/polycystic-ovary-syndrome-pcos-e8PLdw5UDD
Publisher
Wiley
Copyright
Copyright © 2017 RCOG
ISSN
1467-2561
eISSN
1744-4667
DOI
10.1111/tog.12345
Publisher site
See Article on Publisher Site

Abstract

DOI: 10.1111/tog.12345 2017;19:119–29 Review The Obstetrician & Gynaecologist http://onlinetog.org Adam H Balen MD DSc FRCOG* Leeds Centre for Reproductive Medicine, Leeds Teaching Hospitals, Leeds, LS14 6UH, UK *Correspondence: Adam H Balen. Email: a.balen@nhs.net Accepted on 25 July 2016. Published Online 21 January 2017. Key content To appreciate the role of insulin resistance and the long-term The symptoms of polycystic ovary syndrome (PCOS) include health implications for women with PCOS. menstrual cycle disturbance and features of hyperandrogenism To understand how to manage the issues that may affect a woman (hirsutism, acne and alopecia), with associated fertility problems, in different ways at different times in her life, namely menstrual obesity and psychological issues. cycle irregularity, hyperandrogenism and infertility. There are ethnic variations in expression of PCOS related to Ethical issues differences in insulin metabolism and this may impact upon A contentious issue is the appropriateness to deny fertility treatment algorithms. treatment based upon a cut-off for body mass index (BMI), when Obesity has a major impact on the expression of PCOS and the BMI is a crude measure of metabolic risk and the risks of efficacy of the management of all aspects of the syndrome, in conception at a high BMI

Journal

The Obstetrician & Gynaecologist – Wiley

Published: Apr 1, 2017

Keywords: ; ; ; ;

References

  • Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome
  • Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome
    Cussons, AJ; Watts, GF; Burke, V; Shaw, JE; Zimmet, PZ; Stuckey, BG
  • Health‐related quality of life measurement in women with polycystic ovary syndrome: a systematic review
    Jones, GL; Hall, JM; Balen, AH; Ledger, W
  • Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity
    Sivayoganathan, D; Maruthini, D; Glanville, JM; Balen, AH
  • The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
    Barth, J; Yasmin, E; Balen, AH
  • Polycystic ovaries and associated clinical and biochemical features in young women
    Michelmore, KF; Balen, AH; Dunger, DB; Vessey, MP
  • Ultrasound assessment of the polycystic ovary: international consensus definitions
    Balen, AH; Laven, JSE; Tan, SL; Dewailly, D
  • Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
    Dewailly, D; Lujan, ME; Carmina, E; Cedars, MI; Laven, J; Norman, RJ
  • The physiology and clinical utility of anti‐Mullerian hormone in women
    Dewailly, D; Yding Andersen, C; Balen, AH; Broekmans, FJ; Dilaver, N; Griesinger, G
  • Polycystic ovaries and associated clinical and biochemical features in young women
    Michelmore, KF; Balen, AH; Dunger, DB; Vessey, MP
  • Ethnic specific PCOS
    Wijeyeratne, C; Udayangani, D; Balen, AH
  • Polycystic ovary syndrome in south Asian women: a case control study
    Wijeyaratne, CN; Balen, AH; Barth, J; Belchetz, PE
  • Polycystic ovary syndrome and fat distribution: the central issue?
    Lord, J; Wilkin, T
  • Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non‐insulin dependent diabetes mellitus in polycystic ovary syndrome
    Norman, RJ; Masters, L; Milner, CR; Wang, JX; Davies, MJ
  • Cardiovascular disease in women with polycystic ovary syndrome at long‐term follow‐up: a retrospective cohort study
    Wild, S; Pierpoint, T; McKeigue, P; Jacobs, H
  • Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM‐Sponsored 3rd PCOS Consensus Workshop Group
    Fauser, BCJM; Tarlatzis, BC; Rerbar, RW; Legro, RS; Balen, AH; Lobo, R
  • The diagnosis of polycystic ovary syndrome in adolescents
    Carmina, E; Oberfield, SE; Lobo, RA
  • Polycystic ovary syndrome: early detection in the adolescent
    Jeffrey, CR; Coffler, MS
  • Prospective follow‐up of menstrual disorders in adolescence and prognostic factors
    Wiksten‐Almstromer, M; Hirschberg, AL; Hagenfeldt, K
  • Consensus on infertility treatment related to polycystic ovary syndrome
  • The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance)
    Balen, AH; Morley, LC; Misso, M; Franks, S; Legro, RS; Wijeyaratne, CN
  • Impact of obesity on female reproductive health. British Fertility Society, Police and Practice Guidelines
    Balen, AH; Anderson, R
  • Lifestyle changes in women with polycystic ovary syndrome
    Moran, LJ; Hutchison, SK; Norman, RJ; Teede, HJ
  • The role of bariatric surgery in the management of female fertility
    Scholtz, S; Roux, C; Balen, AH
  • Oral anti‐oestrogens and medical adjuncts for subfertility associated with anovulation
    Beck, JI; Boothroyd, C; Proctor, M; Farquhar, C; Hughes, E
  • Modern use of clomifene citrate in induction of ovulation
    Kousta, E; White, DM; Franks, S
  • Hormonal profiles following clomifene citrate therapy in conception and non‐conception cycles
    Shoham, Z; Borenstein, R; Lunenfeld, B; Pariente, C
  • Review: aromatase inhibitors for ovulation induction
    Casper, RF; Mitwally, MF
  • Letrozole versus clomiphene for infertility in the polycystic ovary syndrome
    Legro, RS; Brzyski, RG; Diamond, MP; Coutifaris, C; Schlaff, WD; Casson, P
  • Aromatase inhibitors for subfertile women with polycystic ovary syndrome
    Franik, S; Kremer, JA; Nelen, WL; Farquhar, C
  • Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
    Morley, LC; Tang, T; Yasmin, E; Lord, JM; Norman, RJ; Balen, AH
  • Metformin improves pregnancy and live‐birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double‐blind, placebo‐controlled randomized trial
    Morin‐Papunen, L; Rantala, AS; Unkila‐Kallio, L; Tiitinen, A; Hippeläinen, M; Perheentupa, A
  • Metformin and lifestyle modification in PCOS: systematic review and meta‐analysis
    Naderpoor, N; Shorakae, S; Courten, B; Misso, ML; Moran, LJ; Teede, HJ
  • Using an electrocautery strategy or recombinant FSH to induce ovulation in polycystic ovary syndrome: a randomised controlled trial
    Bayram, N; Wely, M; Kaaijk, EM; Bossuyt, PMM; Veen, F
  • A meta‐analysis of pregnancy outcomes in women with polycystic ovary syndrome
    Boomsma, CM; Eijkemans, MJ; Hughes, EG; Visser, GH; Fauser, BC; Macklon, NS